Stepwise and One Step Techniques In Deep Dentin Lesion
Launched by TIJEN PAMIR · Apr 16, 2020
Trial Information
Current as of May 30, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Molar teeth with primary caries lesion prolonged of 75 percentage or more of dentin radiographically1 Existence of vitality with positive response to
- • electrical pulp test and
- • cold test
- • No history of spontaneous pain on the teeth
- • No sign of pain on percussion and palpation (sensitivity)
- Exclusion Criteria:
- • Individuals with the systemic disease who require hospitalization (oncological treatment, transplantation patients)
- • Patients with uncontrolled hyperglycaemia or using insulin
- • Patients with pregnancy/suspected
- • Observation of radiolucency in the apex of the relevant tooth (PAI\> 2)
- • Secondary decayed teeth
About Tijen Pamir
Tijen Pamir is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on fostering collaboration between healthcare professionals, researchers, and regulatory bodies, Tijen Pamir ensures the rigorous design and execution of clinical trials across various therapeutic areas. The organization prioritizes ethical standards and patient safety, leveraging cutting-edge methodologies to facilitate the development of new therapies. Tijen Pamir's expertise and commitment to excellence position it as a key player in the clinical research landscape, driving progress and enhancing the quality of care in the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tijen Pamir, Ph.D
Study Director
Ege University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials